Cannabis News and Research

Latest Cannabis News and Research

Canaleaf Systems signs definitive agreement to purchase 50% of IHMML

Medican Enterprises Inc. a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce its wholly owned subsidiary Canaleaf Systems Inc. has signed a definitive purchase agreement to acquire 50 percent of International Herbs Medical Marijuana Ltd.

10 Apr 2014

Neutra prepares to roll out new game-changing technology in indoor horticulture industry

As Neutra Corp. (OTCBB: NTRR) and its joint venture partner prepare to roll out a new, game-changing technology in the indoor horticulture industry, the company announced today that work has already begun on new, customizable solutions for growing operations with uncommon requirements.

10 Apr 2014

Neutra seeks new breakthroughs in greenhouse cultivation to develop and market around globe

In the company's quest to introduce new technology on the cutting edge of the indoor horticulture industry, Neutra Corp. (OTCBB: NTRR) is seeking out new breakthroughs in greenhouse cultivation to develop and market around the globe.

8 Apr 2014

New weapon against secondary progressive MS

Statins may provide doctors with an unlikely new weapon with which to slow the progression of multiple sclerosis (MS).

20 Mar 2014

Primco Management agrees to acquire Seattle based Suzie Q's

Primco Management Inc., a fully integrated multi-media entertainment and real estate development company, today announced that the Company has entered into an agreement to acquire Seattle based Suzie Q's, a medical marijuana collective fully licensed by the City of Seattle.

19 Mar 2014

Cannabis and NTRR poised to outpace expansion of global smartphone market

Cannabis is among the fastest-growing markets in the U.S., poised to outpace the expansion of the global smartphone market—and Neutra Corp. (OTCBB: NTRR) is readying a diverse product line to capitalize on that growth.

19 Mar 2014

Drug abuse does not always lead to psychosis readmission

Cannabis or stimulant abuse disorders do not necessarily predict a negative outcome for patients with first-episode psychosis, Australian researchers report.

5 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

3 Mar 2014

U.S study:10% of non-lifetime marijuana users report that they would try marijuana if legal

National support for marijuana ("cannabis") legalization is increasing in the United States (US). Recreational use was recently legalized in the states of Colorado and Washington; other states across the country are expected to follow suit.

26 Feb 2014

Substance abuse worsens course of first-episode psychosis

Patients with first-episode psychosis who also present with substance abuse have a higher rate of hospitalisation after 12 months than their peers who do not, an Italian study reports.

25 Feb 2014

UFCW supports for the efforts of Ohio Rights Amendment

United Food and Commercial Workers (UFCW) members in Ohio today announced their support for the efforts of the Ohio Rights Group and for the Ohio Cannabis Rights Amendment.

20 Feb 2014

Neutra acquires cutting-edge developer of smoke-free nutraceutical delivery systems

Neutra Corp. (OTCBB: NTRR), a fast-growing provider of all-natural wellness solutions, announced today that it acquired Diamond Anvil Designs (DA), a cutting-edge developer of smoke-free nutraceutical delivery systems.

11 Feb 2014

UCSF-led study gathers data on safety, tolerability of purified cannabinoid for children with epilepsy

A new international multi-center study led by researchers from UCSF Benioff Children's Hospital is the first to evaluate whether purified cannabinoid is effective in treating severe forms of childhood epilepsy that do not respond to standard antiepileptic drugs.

5 Feb 2014

State highlights: Will doc cuts like those in Conn. become more common?; Calif. health plans criticized over chronic condition treatment; Vt. drug addiction

A selection of health policy stories from Connecticut, California, Vermont, Minnesota, Virginia and Georgia.

30 Jan 2014

Study details about healthful compounds contained in hempseed

Long stigmatized because of its "high"-inducing cousins, hemp - derived from low-hallucinogenic varieties of cannabis - is making a comeback, not just as a source of fiber for textiles, but also as a crop packed with oils that have potential health benefits.

30 Jan 2014

Cannabis during pregnancy results in defective development of fetal nerve cells

An increasing number of children suffer from the consequences of maternal drug exposure during pregnancy, and Cannabis is one of the most frequently used substances.

27 Jan 2014

Exposing adolescent to marijuana can lead to behavioral alterations in next generation

Exposing adolescent rats to THC (tetrahydrocannabinol) -the primary psychoactive ingredient in marijuana—can lead to molecular and behavioral alterations in the next generation of offspring, even though progeny were not directly exposed to the drug, researchers at the Icahn School of Medicine at Mount Sinai have found.

23 Jan 2014

Social cognitive deficits contribute to perpetuation of cocaine addiction, say scientists

In Europe as well as worldwide, cocaine is the second most frequently used drug after cannabis. Chronic cocaine users display worse memory performance, concentration difficulties, and attentional deficits but also their social skills are affected as previous studies at the Psychiatric Hospital of the University of Zurich suggested.

22 Jan 2014

Synthetic cannabinoid molecule created for osteoarthritis

Chemical compounds synthesised in the laboratory, similar to those found in cannabis, could be developed as potential drugs to reduce the pain of osteoarthritis.

7 Jan 2014